BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 12219049)

  • 1. Bones benefit from better biochemical control in type 1 glycogen storage disease.
    Wolfsdorf JI
    J Pediatr; 2002 Sep; 141(3):308-10. PubMed ID: 12219049
    [No Abstract]   [Full Text] [Related]  

  • 2. Low bone mass in glycogen storage disease type 1 is associated with reduced muscle force and poor metabolic control.
    Schwahn B; Rauch F; Wendel U; Schönau E
    J Pediatr; 2002 Sep; 141(3):350-6. PubMed ID: 12219054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutritional goals in glycogen storage disease.
    Williams JC
    N Engl J Med; 1986 Mar; 314(11):709-10. PubMed ID: 3081808
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging therapies for glycogen storage disease type I.
    Koeberl DD; Kishnani PS; Bali D; Chen YT
    Trends Endocrinol Metab; 2009 Jul; 20(5):252-8. PubMed ID: 19541498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow transplantation in glycogen storage disease type 1b.
    Pierre G; Chakupurakal G; McKiernan P; Hendriksz C; Lawson S; Chakrapani A
    J Pediatr; 2008 Feb; 152(2):286-8. PubMed ID: 18206704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of raw starches in the treatment of type I glycogenosis.
    Sidbury JB; Chen YT; Roe CR
    Arch Intern Med; 1986 Feb; 146(2):370-3. PubMed ID: 3456223
    [No Abstract]   [Full Text] [Related]  

  • 7. Review of the glycogen storage diseases.
    Bitar J
    J Med Liban; 1986; 36(2):72-5. PubMed ID: 3537297
    [No Abstract]   [Full Text] [Related]  

  • 8. Glycogen storage disease type I.
    Schiffrin A; Polychronakos C; Abu-Srair H
    N Engl J Med; 1986 Aug; 315(8):520-1. PubMed ID: 3461279
    [No Abstract]   [Full Text] [Related]  

  • 9. The muscle-bone relationship: methods and management - perspectives in glycogen storage disease.
    Schönau E; Schwahn B; Rauch F
    Eur J Pediatr; 2002 Oct; 161 Suppl 1():S50-2. PubMed ID: 12373571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino acid and hormonal response to long-term nocturnal nasogastric feeding therapy of glycogen storage disease type I (GSD-I).
    Slonim AE; Terry A; Greene HL; Lacy WW; Burr IM
    Monogr Hum Genet; 1978; 9():37-41. PubMed ID: 104149
    [No Abstract]   [Full Text] [Related]  

  • 11. Letter: Nocturnal feeding for glycogen-storage disease.
    Ehrlich RM
    N Engl J Med; 1976 May; 294(20):1125. PubMed ID: 1062677
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of hepatic and brain metabolism in young adults with glycogen storage disease type 1: a magnetic resonance spectroscopy study.
    Weghuber D; Mandl M; Krssák M; Roden M; Nowotny P; Brehm A; Krebs M; Widhalm K; Bischof MG
    Am J Physiol Endocrinol Metab; 2007 Nov; 293(5):E1378-84. PubMed ID: 17785500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased ketogenesis in von Gierke's disease (type I glycogenosis).
    Binkiewicz A; Senior B
    J Pediatr; 1973 Dec; 83(6):973-8. PubMed ID: 4518932
    [No Abstract]   [Full Text] [Related]  

  • 14. Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia.
    Koeberl DD; Sun BD; Damodaran TV; Brown T; Millington DS; Benjamin DK; Bird A; Schneider A; Hillman S; Jackson M; Beaty RM; Chen YT
    Gene Ther; 2006 Sep; 13(17):1281-9. PubMed ID: 16672983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Glycogen metabolism (3), and biochemical aspects of glycogenoses. II. Biological aspect of glycogenoses].
    Gajdos A
    Presse Med (1893); 1967 Apr; 75(21):1059-64. PubMed ID: 5228855
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hepatorenal glycogenoses].
    de Parscau L
    Arch Pediatr; 1994 Apr; 1(4):414-5. PubMed ID: 7842098
    [No Abstract]   [Full Text] [Related]  

  • 17. Two different anesthetic managements of a patient with von Gierke's disease.
    Huang IR; Jean WH; Lu CW; Wu CC; Lin TY; Chuang YH; Sun WZ
    Acta Anaesthesiol Taiwan; 2006 Mar; 44(1):51-3. PubMed ID: 16623410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage disease type I: effect of continuous nocturnal nasogastric feeding.
    Davidson AG; Wong LT; Kirby L; Tze WJ; Rigg JM; Applegarth DA
    Monogr Hum Genet; 1978; 9():29-36. PubMed ID: 104148
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glycogen storage disease type I--advances in diagnostic strategies and therapeutic measures].
    Moses S; Hershkovitz E; Parvary R; Bashan N
    Harefuah; 1995 May; 128(10):626-30. PubMed ID: 7601378
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on dietary correction of metabolic abnormalities in hepatorenal glycogenosis.
    Kelsch RC; Oliver WJ
    Pediatr Res; 1969 Mar; 3(2):160-70. PubMed ID: 5253123
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.